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ABSTRAK 
 
Pengenalan: Masa dan kaedah yang terbaik untuk mengambil bacaan tekanan darah 
dalam kalangan pesakit kegagalan buah pinggang peringkat akhir yang sedang menjalani 
rawatan haemodialisis masih belum dapat ditentukan. Selepas prosedur haemodialisis, 
plasma dari interstitium akan kembali ke dalam salur darah. Masa sebenar proses 
keseimbangan berlaku tidak diketahui. Diameter “inferior vena cava” mencapai ukuran 
normal apabila pesakit dalam keadaan “euvolemia”. Kaedah ukuran ultrasonografi secara 
langsung boleh digunakan unutk mengetahui samaada pesakit telah mencapai 
“euvolemia”. Masa apabila diameter “inferior vena cava” normal adalah waktu terbaik 
untuk mengambil tekanan darah memandangkan pada saat ini paras air dalam badan 
adalah normal.    
Objektif: Mengenalpasti waktu yang paling tepat untuk mengambil tekanan darah 
selepas rawatan haemodialisis.  Mengenalpasti variabiliti tekanan darah dalam tempoh 24 
jam termasuk 4 jam selepas dialisis. 
Kaedah: Ini adalah satu kajian keratan rentas melibatkan 14 pesakit buah pinggang yang 
menjalani rawatan hemodialisis secara berkala di pusat hemodialisis, HUSM. Pesakit 
diminta memakai alat tekanan darah 24 jam yang akan mengambil tekanan darah setiap 
jam selama 24 jam bermula hari sebelum hemodialisis sehingga 4 jam selepas 
hemodialysis. Selepas hemodialisis, diameter “inferior vena cava” dan tekanan darah 
akan diukur pada 10, 30 dan 60 minit selepas tamat rawatan hemodialisis. Keputusan 
dipersembahkan dalam bentuk median untuk data yang taburannya tidak normal dan 
purata untuk data yang taburannya normal. 
Keputusan: Diameter vena cava inferior pada 10 minit selepas hemodialisis adalah kecil, 
kemudian menjadi normal pada 30 minit dan tiada perubahan pada 60 minit. Tekanan 
xi 
 
darah selepas hemodialisis lebih menghampiri nilai purata pada waktu 60 minit selepas 
dialisis. Kajian ini juga mendapati tiada perbezaan ketara dari segi perubahan purata 
tekanan darah 24 jam.  
Kesimpulan: Waktu yang paling tepat untuk mengambil bacaan tekanan darah selepas 
rawatan haemodialisis adalah selepas 60 minit. Kajian ini juga mendapati tiada perbezaan 
ketara dari segi perubahan purata tekanan darah.  
 
Kata kunci: kegagalan buah pinggang peringkat akhir, hemodialisis, diameter “inferior 
vena cava”  
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ABSTRACT 
 
Introduction:  The appropriate time and method of blood pressure measurement in end 
stage renal failure (ESRF) patients on regular hemodialysis is still uncertain. During post-
hemodialysis, refilling of plasma volume from the interstitium took place. Therefore, the 
exact timing of when blood volume reaches equilibrates is uncertain. The inferior vena 
cava diameter normalizes when patient is euvolemic. Therefore, ultrasonographic direct 
measurement of inferior vena cava can be used to reflect the euvolemic state.  
Objectives: To determine the best time to measure post-hemodialysis blood pressure in 
ESRF patients on regular hemodialysis. To determine the variability of 24 hours blood 
pressure readings. 
Method: This is a cross sectional study involving 14 ESRF patients on regular 
hemodialysis in the HUSM outpatient hemodialysis unit. Hourly blood pressure reading 
was taken using ambulatory blood pressure monitoring device, starting from a day before 
hemodialysis session and 4 hours of post-hemodialysis, total duration of 24 hours. Upon 
completion of the hemodialysis treatment, serial ultrasonographic inferior vena cava 
diameter measurements were performed at 10, 30 and 60 minutes post-hemodialysis. 
Simultaneously, blood pressure readings were also taken at 10, 30 and 60 minutes post-
hemodialysis. Results were expressed as median (interquartile range) for data that was not 
normally distributed and described as mean (standard deviation) for normally distributed 
data. Repeated measure ANOVA was used to test for significance of blood pressure 
variability.   
Results: The inferior vena cava diameter was small at 10 minutes post-hemodialysis but 
it become normalize at 30 minutes and not much difference at 60 minutes. Blood pressure 
xiii 
 
at 10, 30 and 60 minutes was found to be closer to average value at 60 minutes. 
Variability of the average blood pressure was not significant. 
Conclusions: The optimal time for blood pressure measurement in end stage renal failure 
patients on regular hemodialysis was found to be at 60 minutes post-hemodialysis based 
on euvolemic state reflected by IVC diameter. This study also found that there was no 
significant difference in blood pressure variability from one person to another.  
 
Keywords: end stage renal failure, hemodialysis, inferior vena cava diameter 
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timing of when blood volume reaches equilibrates is uncertain. The inferior vena cava diameter 
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was taken using ambulatory blood pressure monitoring device, starting from a day before 
hemodialysis session and 4 hours of post-hemodialysis, total duration of 24 hours. Upon 
completion of the hemodialysis treatment, serial ultrasonographic inferior vena cava diameter 
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pressure readings were also taken at 10, 30 and 60 minutes post-hemodialysis. Results were 
expressed as median (interquartile range) for data that was not normally distributed and described 
as mean (standard deviation) for normally distributed data. Repeated measure ANOVA was used 
to test for significance of blood pressure variability.   
 
Results: The inferior vena cava diameter was small at 10 minutes post-hemodialysis but it 
become normalize at 30 minutes and not much difference at 60 minutes. Blood pressure at 10, 30 
and 60 minutes was found to be closer to average value at 60 minutes. Variability of the average 
blood pressure was not significant. 
 
Conclusion: The optimal time for blood pressure measurement in end stage renal failure 
patients on regular hemodialysis was found to be at 60 minutes post-hemodialysis based on 
euvolemic state reflected by IVC diameter. This study also found that there was no significant 
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CHAPTER 1  
INTRODUCTION  
1.1 Background of the Study  
1.1.1 End Stage Renal Failure (ESRF) 
The prevalence of chronic kidney disease (CKD) and end-stage renal failure (ESRF) 
is increasing worldwide. The overall prevalence of chronic kidney disease in West Malaysia 
was 9.07% (Hooi et al., 2013).  In 2013, there were 31,637 patients receiving dialysis in 
Malaysia, significantly increased from 11,842 in 2004. The new intake of dialysis patients 
had doubled from only 2,901 in 2004, to 6,222 in 2013 (BL Goh et al., 2014). 
There are many causes of chronic kidney diseases. In Malaysia, diabetic kidney 
disease (DKD) is the main cause of ESRF, contributing to 61% of new patients accepted for 
hemodialysis (BL Goh et al., 2014). Other causes of ESRF include hypertension, 
glomerulonephritis, drug-induced, obstructive uropathy, polycystic kidney disease and 
bilateral renal artery stenosis (Li PKT et al., 2011).  
Patients who suffered from ESRF require RRT to sustain life. The modalities 
available for RRT include hemodialysis, hemodiafiltration, peritoneal hemodialysis and renal 
transplantation.  Mode of RRT depends on several factors, including the primary need (e.g. 
solute or water removal or both), hemodynamic stability, vascular access, local expertise, 
availability, and patient preference and capability (e.g. for home dialysis). A survey in 2005 
which utilized the Fresenius medical care network, has estimated 1.3 million patients 
received RRT worldwide, of which 89% received hemodialysis and 11% received peritoneal 
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dialysis  (Grassmann et al., 2005). In Malaysia, the incidence and prevalence of patients on 
dialysis were 210 and 1,065 per million populations in 2013. Most (90%) of these patients 
were on hemodialysis, with only a small percentage (10%) were on peritoneal dialysis (BL 
Goh et al., 2014). 
1.1.2 Burden of ESRF 
The increasing number of ESRF places significant burden on the health care system 
in terms of human and socioeconomic burden. Patient with ESRF has a signiﬁcantly reduced 
life span; many amongst them would meet with an untimely demise mainly due to 
cardiovascular complication. 
ESRF is considered as the most expensive chronic disease. This is due to the high 
costs of the treatment modalities (i.e. hemodialysis and kidney transplant). The costs of 
dialysis and transplantation consume disproportionate amounts within the health-care 
budgets in all jurisdictions which is 5% of annual budgets consumed by less than 1% of the 
population (Ministry of Health, 2011). In an economic evaluation among Ministry of Health 
hemodialysis centres in Malaysia, it was found that the cost of hemodialysis and 
erythropoietin was RM2500 per month. A study in the United States has found that the cost 
of medical care was 1.7 times higher in patients with CKD stage 3 and 2.6 times higher in 
those with stage 4 CKD compared with control (Smith DH et al., 2004). 
ESRF also place a significant social burden as illustrated in the paper by Tan et al,  
“Why patients say, ‘No’ to RRT” (Tan L et al., 2013). Their analysis of 24 patients showed 
that the most common reason why patient did not undergo RRT was because the family 
members or caregivers who refused and not patient themselves refused. Such patients did not 
have a good family or social support. Their relatives are not keen to take them home after 
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discharge, meaning they usually have no home to go to. If they do bring patients home, they 
opt for conservative treatment at home without any form of RRT, because either very few 
caregivers are willing to bring these patients to and from the hemodialysis centres for 
hemodialysis thrice weekly or not many caregivers can help to perform the peritoneal 
dialysis exchanges 4 times a day at home.  
1.2 Hypertension in ESRF patients 
1.2.1 Prevalence of hypertension in ESRF patients  
According to Malaysia Clinical Practice Guidelines for Management of Hypertension 
2013, hypertension is defined as persistent elevation of systolic BLOOD PRESSURE of 140 
mmHg or greater and/or diastolic BLOOD PRESSURE of 90 mmHg or greater (Ministry of 
Health 2013). The prevalence of hypertension in hemodialysis patients and those with ESRF 
is much higher than in the general population, reaching 70%–80% (Charra et al., 2004; Kiss 
et al., 2005). Despite its high prevalence, there is limited knowledge on optimal control and 
hypertension management in hemodialysis patients (Peixoto and Santos, 2010). 
1.2.2 Control of hypertension in ESRF patients 
Hypertension management is difficult in hemodialysis patients because of the 
significant variation in blood pressure between pre-, post- and inter-dialytic period (Ekart et 
al., 2011). According to 19th Report of the Malaysian Dialysis and Transplant Registry 2011, 
“The difficulty in controlling pre-hemodialysis systolic blood pressure in hemodialysis 
patients persisted in 2011 with only 26% of hemodialysis patients achieving systolic blood 
pressure <140 mmHg in 2011” (Lim YN et al., 2012). 
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1.2.3 Complication of hypertension in ESRF patient 
Uncontrolled hypertension in pre-dialysis patients has been identified as a major risk 
factor for progressive kidney dysfunction and also increased rate of cardiovascular 
complications. At the stage of, this hemodynamic abnormality can increase cardiovascular 
mortality by 3-fold (Lucas et al., 2003). It is also associated with an annual mortality of 43% 
higher compared to person without renal disease (USRDS, 2012) and the mortality is 
contributed mainly from cardiovascular disease (Locatelli et al., 2004). 
1.3 Justification and Rationale of Study 
Post-hemodialysis blood pressure measurement of ESRF patients is not accurate if 
taken immediately after hemodialysis. This is due to the nature of the hemodynamic 
instability that occurs prior to the equilibration between the intravascular and extravascular 
space. In the euvolemic state, evidenced by normalized inferior vena cava diameter, blood 
pressure recordings can be considered near to the accuracy. Therefore, determination of the 
right time to measure blood pressure post-hemodialysis will assist clinician in the 
hypertension management. 
The rationale of carrying out this study is to identify the best possible time for blood 
pressure measurement in ESRF. 
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CHAPTER 2  
LITERATURE REVIEW 
2.1 Blood pressure measurement in hemodialysis patients 
2.1.1 Options of blood pressure measurement  
There are several options at which blood pressure are being measured in hemodialysis 
patients. These include pre- or post-dialysis blood pressure, ambulatory blood pressure 
monitoring (ABPM), and inter-dialytic home blood pressure. However the most appropriate 
time of blood pressure measurement in hemodialysis patients is still uncertain. There is no 
consensus of what is the best option to measure blood pressure (Levin et al., 2010; Ekart et 
al., 2011). 
National Kidney Foundation Kidney Disease Outcomes Quality Initiative guidelines 
suggest that pre-hemodialysis and post-hemodialysis blood pressure should be 140/90 and 
130/80 mmHg, respectively (Stidley et al., 2006). 
It is unclear as to which time of blood pressure measurement best reflects the burden 
of hypertension and correlates best with cardiovascular outcomes (Rahman et al., 2002). 
Management decisions were confounded by the variability of these blood pressure 
measurements. This variability contributes to its difficulty to ascertain the optimum timing 
and method of blood pressure measurement (Levin et al., 2010).  
2.1.2 Pre- and post-hemodialysis blood pressure measurement  
Agarwal (2003) found that the blood pressure is often extraordinarily elevated prior to 
hemodialysis and changed to hypotensive levels during hemodialysis. These changes in 
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blood pressure within a short duration of time make the application of the traditional 
definitions of hypertension problematic. In fact, blood pressure fluctuates so much that the 
variability within patients from one visit to the next is about the same as between patients 
(Rohrscheib et al., 2008). He found that the standard deviation of pre-hemodialysis systolic 
blood pressure between patients is 17.9 mmHg whereas visit-to-visit standard deviation 
within patient is 18.0 mmHg whereas the standard deviation for post-hemodialysis BP 
between patients is 17.4 mmHg and within patient 18.4 mmHg (Rohrscheib et al., 2008). 
Routine peri-hemodialytic blood pressure recordings performed by a hemodialysis 
unit staff shortly before and after the hemodialysis session are highly variable and poorly 
reproducible (Agarwal et al., 2006a; Rohrscheib et al., 2008) and do not correlate well with 
end-organ damage (Agarwal et al., 2006b; Alborzi et al., 2007). Nevertheless, peri-
hemodialysis blood pressure measurements are used for management of hypertension in the 
majority of hemodialysis patients today (Sinha and Agarwal, 2009). 
2.1.2.1 Pre-hemodialysis blood pressure measurement 
According to Zoccali (2003), pre-hemodialysis blood pressure was a better predictor 
of left ventricular mass index than post-hemodialysis blood pressure. Pre-hemodialysis blood 
pressure also generally overestimate the ambulatory blood pressure with wide agreement 
limits (23.7 to 18.9 mmHg) (Agarwal et al., 2006c).  
2.1.2.2 Post-hemodialysis blood pressure measurement 
Post-hemodialysis blood pressure underestimate average ambulatory blood pressure 
with wide agreement limits for both post-hemodialysis systolic blood pressure  (33.1 to 
36.3mmHg) and diastolic blood pressure  (19.3 to 23.9 mmHg) (Agarwal et al., 2006c).  
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Another option exists, that is the inter-hemodialytic period. Even when blood 
pressure is recorded in the inter-hemodialytic period, the timing is critically important. Other 
studies found large variations of blood pressure readings when it is recorded 12 hours versus 
36 hours after termination of hemodialysis (Kelley et al., 2007; Agarwal and Light, 2009). 
Furthermore, the inter-hemodialysis weight gain affects the rate of rise in inter-hemodialysis 
blood pressure. The rate of change in both the systolic and diastolic blood pressure are more 
abrupt when the inter-dialytic weight gain is excessive (Kelley et al., 2007; Agarwal and 
Light, 2008). In contrary, the decline in blood pressure is more marked when more 
ultrafiltration is performed during hemodialysis. 
2.1.3 Ambulatory blood pressure monitoring (ABPM) 
ABPM remains the gold standard to quantify the integrated blood pressure load 
applied to the cardiovascular system (Saint-Remy and Krzesinski, 2005; Pickering et al., 
2006; Agarwal, 2012). Out-of-office blood pressure measurements (home blood pressure or 
ambulatory blood pressure monitoring) are better predictors of target organ damage and 
mortality in patients with essential hypertension and in patients with kidney disease (Peixoto 
and Santos, 2010). ABPM has been generally considered as the most accurate method for 
evaluating blood pressure load in the general population as well as in hemodialysis patients 
(Peixoto et al., 2000; Pickering et al., 2006).  
ABPM has been shown to predict cardiovascular events better than conventional 
blood pressure measurement in patients with essential hypertension. Although measurement 
of ABPM nor self-measured home blood pressure better than peri-dialysis blood pressure 
measurement, they may not be feasible or practical for most patients throughout the world, 
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leaving pre-hemodialysis and post-hemodialysis blood pressure measurements to be used, but 
with caution and with the knowledge that these are inferior (Levin et al., 2010).  
2.2 Relationship between blood pressure and volume  
A direct relationship between volume status and blood pressure in patients with ESRF 
treated with hemodialysis has long been recognized. An increase in pre-hemodialysis systolic 
blood pressure may reflect hypervolemia. Data from the CRIT-Line Intra-dialytic Monitor 
Benefit (CLIMB) Study obtained during 32 295 sessions of 442 subjects followed up for 6 
months confirmed that an increasing percentage of inter-hemodialysis weight gain is 
associated with a higher pre-hemodialysis blood pressure and a greater decrease in blood 
pressure associated with hemodialysis. However, the magnitude of the relationship between 
blood pressure and inter-dialytic weight gain, was found to be modest and modified by other 
clinical factors such as malnutrition or inflammation (Inrig et al., 2007). Nevertheless, 
hemodialysis patients with a 15% or greater extracellular volume increase over the normal 
were at an increased risk of mortality (Wizemann et al., 2009).  
Salt and water overload is a key component of high blood pressure in dialysis 
patients. Therefore, controlling the body sodium content and the extracellular volume is the 
essential in controlling blood pressure and reducing the cardiovascular mortality in this 
patient population (Charra, 2007). If volume is strictly under control, antihypertensive drug 
treatment may be unnecessary and may even be dangerous (Tomson, 2009). 
Antihypertensive drugs may interfere with the compensatory vasoconstriction in blood 
pressure maintenance in the face of rapid changes in intravascular volume during 
conventional hemodialysis (Tomson, 2009). 
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Volume status of ESRF patients influences both pre- and post-hemodialysis blood 
pressure. Volume status is perhaps the most important factor in the development and 
maintenance of hypertension in dialysis patients (Mailloux and Haley, 1998). It has been 
shown that normotensive patients have significantly less total body water than hypertensive 
hemodialysis patients, demonstrating the importance of intravascular volume in the 
pathogenesis of hypertension in patients with ESRF (Lins et al., 1997) 
Even though volume plays an important part in high blood pressure in this population, 
not all hypertensive patients are volume overloaded. This is shown by study by Wabel et al. 
(2008) who illustrated the wide variability in systolic blood pressure regardless of the degree 
of change in hydration status from normal ranges. In this study of 500 hemodialysis patients, 
a new bio-impedance spectroscopy device was selected that allows quantitative 
determination of the deviation in hydration status from normal ranges and a graphical tool 
(hydration reference plot) was devised allowing deviation of hydration status to be combined 
with measurements of systolic blood pressure enabling comparison with a matched healthy 
population (1244 healthy participant). They have found that in only 15% of patients (n = 74) 
was hypertensive, observed blood pressure (systolic blood pressure >150 mmHg) with a 
concomitant deviation from hydration status >2.5 L (possible volume-dependent 
hypertension). In contrast, 13% of patients (n = 69) were hypertensive with deviation from 
hydration status <1.1 L (possible essential hypertension). In 10% of patients (n = 52), systolic 
blood pressure <140 mmHg was recorded despite deviation from hydration status exceeding 
2.5 L (Wabel et al., 2008).  
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2.3 Inferior vena cava (IVC) diameter  
2.3.1 Relationship between inferior vena cava and volume 
Inferior vena cava is a highly collapsible vein. Its diameter and collapsibility on deep 
inspiration allow evaluation of the intravascular volume. It correlates well with central 
venous pressure, and it can detect intravascular overload and depletion in hemodialysis 
patients. Non-invasive and fast, it reflects well the plasma but not the interstitial volume, and 
it varies widely as a function of heart function. Agarwal et. al. found that IVC diameter is 
modifiable with dry weight reduction, thus, it reflects in part intravascular volume (Agarwal 
et al., 2011). 
The IVC diameter is not affected by body's compensatory vasoconstrictor response to 
volume loss (Nette et al., 2006). Therefore, IVC diameters reflect volume status more 
accurately compared to other parameters based on arterial system such as blood pressure and 
pulse rate. Studies have shown that IVC diameter is useful in monitoring volume status in 
patients undergoing hemodialysis and in patients under mechanical ventilation in intensive 
care units (Feissel et al., 2004).  
The IVC size varies with changes with intravascular pressure. Consequently, the IVC 
collapses with inspiration as the blood is pumped out of the IVC due to the negative pressure 
created by chest expansion. In healthy subjects breathing spontaneously, cyclic changes in 
thoracic pressure, result in collapse of the IVC diameter of approximately 50% (Pinsky et al., 
2006).  
The pioneering study by Cheriex et al. (1989) in 18 hemodialysis patients suggested 
the usefulness of IVC diameter and its collapse with inspiration as a marker of volume. These 
authors reported a good relationship between IVC diameter and right atrial pressure and 
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between collapse index and right atrial pressure; right atrial pressure was measured 
invasively. Collapse index was found not to correlate with changes in blood volume. Another 
recent study by Agarwal also concluded that collapse index was found to be of limited value 
(Agarwal et al., 2011). 
2.3.2  Inferior vena cava relationship with blood pressure 
IVC diameter in expiration and inspiration and the left atrial diameter are volume 
responsive. Hence, they are at least partly markers of volume.  However, as reported by 
Agarwal et al. (2011), echocardiographic volume parameters at baseline are poor 
determinants of inter-dialytic blood pressure. The author gave three possible explanations for 
these apparently discrepant findings.  
First, echocardiographic parameters did not reflect the expanded extracellular fluid 
volume that is more closely related to hypertension, it only reflect intravascular volume. In 
the post-hemodialysis state, even when patients are volume expanded, an increased rate of 
ultrafiltration may shrink echocardiographic volume and falsely classify these patients as 
under-volume when they are actually volume overload. In fact, IVC expands because of 
vascular refilling; this rate of refilling is more rapid in patients who has more aggressive 
ultrafiltration such as in shorter hemodialysis (Agarwal, 2012)  
Second, different patients may have different sensitivities to volume. For some 
patients, a small reduction of IVC or left atrial diameter may lead to a large change in blood 
pressure, whereas for others, a large change may be needed to affect a drop in blood pressure. 
Thus, this may affect the overall relationship between echocardiographic volume and change 
in blood pressure.  
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Third, the diameter of IVC and atrial diameter may be affected by venous 
compliance. For example, a small change in volume may lead to large changes in diameter in 
those with low venous compliance. Thus, venous compliance can confound the measurement 
of intravascular volume (Agarwal et al., 2011). 
2.3.3 IVC diameter post-hemodialysis 
The timing of measurement is very important, because of the refill of plasma volume 
from the interstitium after hemodialysis. Especially when measured directly after 
hemodialysis, IVC echography may inappropriately suggest a hypovolemic state, because of 
the fact that refill of plasma volume from the interstitium is not yet complete. However, 
performing vena cava echography is operator dependent and not widely available (Charra, 
2007). 
2.3.3 Normal range of IVC diameter  
Although there is a lack of universally accepted cut-offs, in healthy individuals, IVC 
diameter at inspiration ranges from 0 to 14mm at rest, and expiratory diameter of 15 to 
20mm at rest (Field et al., 2012). 
2.3.4 Factors affecting IVC diameter 
Inferior vena cava diameters are not exclusively influenced by the fluid status of a 
given patient. It may be influenced by the presence of tricuspid regurgitation and diastolic 
dysfunction. The IVC may also be dilated in normal young athletes, and in this population, it 
may not reflect elevated right atrial pressure (Lang et al., 2005). However, hemodialysis 
patient are not usually young athletes. Since IVC diameter is measured by using ultrasound, 
it is operator dependent. 
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2.3.5 Measurement of IVC diameter  
In this study, measurement of inferior vena cava diameter follows the guideline from 
American Society of Echocardiography. According to the guideline, the subcostal view is 
most useful for imaging the IVC, with the IVC viewed in its long axis. The guideline further 
states that diameter of the IVC should be measured with the patient in the left decubitus 
position at 1.0 to 2.0 cm from the junction with the right atrium and to accurately assess IVC 
collapse, the change in diameter of the IVC with a sniff and also with quiet respiration should 
be measured, ensuring that the change in diameter does not reflect a translation of the IVC 
into another plane (Lang et al., 2005). 
 
14 
 
CHAPTER 3  
OBJECTIVES, RESEARCH QUESTIONS, HYPOTHESIS  
3.1 Objectives 
3.1.1 General 
To determine the optimal time to measure post-hemodialysis blood pressure in ESRF 
patients at euvolemic state evident by normalization of IVC diameter. 
3.1.2 Specific 
1. To measure inferior vena cava diameter 10 minutes, 30 minutes and 1 hour after 
completed hemodialysis. 
2. To measure post-hemodialysis blood pressure 10 minutes, 30 minutes and 1 hour 
after completed hemodialysis. 
3. To assess the variability of blood pressure among ESRF patients on regular 
hemodialysis by using ambulatory blood pressure measurement device to record 
hourly blood pressure for 24 hours.   
3.2 Research Question 
1. To assess when will IVC diameter normalize after hemodialysis 
2. To assess when is the near accurate time to measure post-hemodialysis blood pressure 
in ESRF patients 
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3. To assess what is the variability of blood pressure in ESRF patients on regular 
hemodialysis 
3.3 Hypothesis 
1. The earliest time IVC diameter start to normalize can either be at 30 minutes or 60 
minutes post hemodialysis. 
2. Post-hemodialysis blood pressure readings when the IVC diameter normalizes will be 
the near accurate blood pressure readings for ESRF patients 
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CHAPTER 4  
 METHODOLOGY 
4.1 Study Design  
Cross sectional study 
4.2 Study Period  
January 2014 to May 2014 
4.3 Reference Population  
ESRF patients on regular hemodialysis in Kelantan 
4.4 Source population 
ESRF patients on regular hemodialysis, at outpatient Hemodialysis Unit, Hospital University 
Sains Malaysia  
4.5 Inclusion criteria   
1. Age ≥ 18 years  
2. On regular hemodialysis therapy three times per week for at least more than 3 months  
4.6 Exclusion Criteria 
1. Recent adverse cardiovascular events 
2. Signs of current infection  
3. Active auto-immune disease 
4. Advanced or severe liver disease 
17 
 
4.7 Sampling Frame 
Patient registry at outpatient Hemodialysis Unit, Hospital University Sains Malaysia  
4.8 Sample Size Calculation  
Sample size was calculated using the following formula for single mean: 
 
Where: 
n= sample size 
Z= value from the standard normal distribution reflecting the confidence level that 
will be used. Thus, for confidence interval of 95%, Z = 1.96 
SD= standard deviation 
∆= detectable differences 
Based on the above formula, 
1. The sample size calculation for objective 1 is as follows:  (reference for standard 
deviation was taken from (Brennan et al., 2006) 
 
 𝑛 =  (
1.96 𝑥 6
4
)
2
= 8.6 
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2. For objective 2, the calculated sample size is shown below: (standard deviation taken 
from (Agarwal et al., 2011)) 
a. systolic blood pressure 
 
𝑛 =  (
1.96 𝑥 18.3
11
)
2
 
𝑛 =  10.6 
a. diastolic blood pressure 
 
𝑛 =  (
1.96 𝑥 11.2
7
)
2
=  9.8 
3. The calculation of sample size for objective 3 is described below (standard deviation 
taken from (Rossignol et al., 2012)):  
b. systolic blood pressure  
 
𝑛 =  (
1.96 𝑥 16.37
10
)
2
=  10.3 
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c. diastolic blood pressure 
 
𝑛 =  (
1.96 𝑥 8.61
5
)
2
 
𝑛 =  11.4 
Thus, the largest calculated sample size is 11.4. Assuming 20% drop rate, the final 
sample size would be 11.4 + 2.3= 13.7, rounded to 14.  
4.9 Sampling Method 
All eligible respondents were included in the study via convenient sampling 
4.10 Research Tool 
4.10.1 Echocardiogram machine 
Brand:   Philips  
Type:   Sonos 5500  
Model no:   MCMD02AA,  
Manufactured:  Massasschusets, USA, year 2003.  
4.10.2 Ambulatory blood pressure measurement set 
Brand :  Spacelabs healthcare  
Model no:   040-1546-00,  
Manufactured : Hertford, UK, year 2010,  
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**calibration was done before each recordings. 
4.11 Data Collection  
4.11.1 Recruitment of research participant  
Patients that are listed in the hemodialysis unit patient registry that underwent 
hemodialysis at HUSM outpatient Hemodialysis Unit, were included in the study if they 
fulfilled the inclusion and exclusion criteria. Sampling method is based on convenient 
sampling. 
Eligible patient were invited to join the study and preliminary information on the 
research were given. Agreed volunteers were given specific date for appointment in CKD 
Resource Center, Hospital USM 
4.11.2 Ambulatory blood pressure monitoring (ABPM) 
Selected patient were given a detailed explanation regarding the study and informed 
consent were recorded. Patients were asked to wear the ambulatory blood pressure 
monitoring device in their non-access arm in the evening before their next hemodialysis 
session. The ABPM was applied for 24 hours, inclusive the 4 hours post hemodialysis.  
The device was calibrated by the researcher and a dedicated medical assistant before 
applying to the patient. Device application was explained by the researcher to the patient. It 
is compulsory for the patient to wear the device for 24 hours.  
4.11.3 Serial IVC and blood pressure measurement 
Patients presented for hemodialysis via arterio-venous fistula. None of them had 
hemodialysis via catheter. Upon completion, blood pressure and IVC diameter were 
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measured at 10, 30 and 60 minutes post-hemodialysis. All patients received normal sodium 
dialysate concentration 1.25mmol/L. 
 Blood pressure at 10, 30 and 60 minutes post- measurements were performed by 
trained hemodialysis nurses according to the American heart Association guidelines, using a 
mercury sphygmomanometer with an appropriate cuff at the arm without arterio-venous 
fistula. Measurements were systematically performed post-dialysis after a 10-minute rest, 
with the patient relaxed and seated with legs uncrossed and back and arm supported, and the 
cuff and the mercury reservoir at the level of the heart. Three consecutive measurements 
were performed 2 minutes apart, in the same arm with the patient in the same position, and 
the mean value was recorded by the researcher.  
The IVC diameter measurement was performed by a single experienced and trained 
echocardiography technician. The measurement procedure were as follows: The IVC was 
visualized in two dimensions, subcostal view for the IVC imaging, viewed in its long axis. 
The measurement of the IVC diameter was made at both end-expiration and inspiration, 
diameter of the IVC was measured with the patient in the left decubitus position at 1.0 to 
2.0mcm from the junction with the right atrium and to accurately assess IVC collapse, the 
change in diameter of the IVC with a sniff and also with quiet respiration were measured, 
ensuring that the change in diameter does not reflect a translation of the IVC into another 
plane. Valsalva manoeuver was avoided. 
4.12 Data Entry and Statistical Analysis 
Data was entered into SPSS version 20 and was analyzed. Data were expressed as 
median ± interquartile range (IQR) for IVC diameter and diastolic blood pressure since the 
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data was not normally distributed while for systolic blood pressure readings data was 
expressed as mean ± standard deviation (SD). Repeated measure ANOVA was used to test 
for significance of blood pressure variability.   
4.13 Ethical issues  
The main ethical issue in this study is regarding the use of ambulatory blood pressure 
device. Since patient need to wear it for 24 hours with hourly blood pressure measurement, 
patient’s daily activity especially sleep maybe interrupted.  
This study was approved by the local research ethical committee, University Sains 
Malaysia (ref: USM/JePeM/278.3. (1) on 28
th
 January 2014. 
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4.14 Flow chart of study 
 
Research writing & presentation 
Analyze data 
Data collection 
24  hour ambulatory BP reading 
started a day before dialysis until 4 
hours post-dialysis 
IVC diameter and BP measurement 
10, 30 and 60 min post-dialysis  
Sample (n=14 ) 
Eligible samples based on : 
Inclusion criteria Exclusion criteria 
Sampling frame 
Patient registry at outpatient haemodialysis unit HUSMS Kelantan 
Source population 
ESRF patients on regular haemodialysis at outpatient haemodialysis unit 
HUSM  
Reference population  
ESRF patients on regular haemodialysis in Kelantan 
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CHAPTER 5   
RESULTS  
5.1 Profiles of hemodialysis patients participating in the study   
 A total of 14 ESRF patients consented and volunteered to participate in this study. 
They regularly underwent three times-per-week hemodialysis sessions in Hospital University 
Sains Malaysia.  All respondents were Malays.  
5.1.1 Socio-demographic characteristic 
The socio-demographic characteristics of the study subjects as shown in Table 5.1. 
The mean (SD) age of patients participated were 50 (17.69) years. Their age ranging was 
from 17 to 77 years old.  Eleven of them were male participants. The mean (SD) of their 
BMI was 22.74 (3.26), corresponding within the normal range. None of them smoke, 
however 42.9% had history of smoking before.   
Table 5.1: Socio demographic characteristic of hemodialysis patients (n=14) 
Characteristics n (%) 
Age (year) 50 (17.69)
a
 
Gender  
Male 11 (78.6%) 
Female 3 (21.4%) 
BMI (kg/m
2
) 22.74   (3.26)
a 
Smoking history  
Previous  6   (42.9) 
Never 8   (57.1) 
a 
mean (SD) 
